SCHEMBL19348649

SCHEMBL19348649

CCCCN(CCCC)CCCC.O=P(O)(O)F.O=P(O)(O)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.50
MMP2 P08253 1/20 0.50
MMP3 P08254 1/20 0.50
MMP8 P22894 1/20 0.50
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA9 Q16790 2/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
LPAR3 Q9UBY5 4/20 0.41
LPAR2 Q9HBW0 1/20 0.41
S1PR2 O95136 1/20 0.41
S1PR1 P21453 1/20 0.41
S1PR3 Q99500 1/20 0.41
S1PR5 Q9H228 1/20 0.41
KDM5A P29375 3/20 0.40
FDPS P14324 4/20 0.40
LPAR1 Q92633 1/20 0.39
GGPS1 O95749 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28655069 1.00 MMP1 (0.50) MMP1MMP2MMP3MMP8CA12
SCHEMBL28655070 1.00 MMP1 (0.50) MMP1MMP2MMP3MMP8CA12
SCHEMBL19348650 0.95 MMP1 (0.50) MMP1MMP2MMP3MMP8CA12
SCHEMBL19350107 0.91 MMP1 (0.47) MMP1MMP2MMP3MMP8CA12
Phosphoric Acid SCHEMBL5052596 0.90 MMP1 (0.54) MMP1MMP2MMP3MMP8CA12
Phosphoric Acid SCHEMBL647323 0.90 MMP1 (0.54) MMP1MMP2MMP3MMP8CA12
Phosphoric Acid SCHEMBL5052603 0.90 MMP1 (0.54) MMP1MMP2MMP3MMP8CA12
Phosphoric Acid SCHEMBL310173 0.90 MMP1 (0.54) MMP1MMP2MMP3MMP8CA12
Phosphoric Acid SCHEMBL1334842 0.90 MMP1 (0.54) MMP1MMP2MMP3MMP8CA12
Phosphoric Acid SCHEMBL4713937 0.90 MMP1 (0.54) MMP1MMP2MMP3MMP8CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3222624-B1 IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME CENTRAL GLASS CO LTD (JP) 2019-11-06 EP disclosed
US-10287165-B2 Imidic acid compound having divalent anion and process for producing the same CENTRAL GLASS CO., LTD. (JP) 2019-05-14 US disclosed
EP-3222624-A1 IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME Central Glass Co., Ltd. (JP) 2017-09-27 EP disclosed
US-20170267528-A1 IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME CENTRAL GLASS CO., LTD. (JP) 2017-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170267528-A1 IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME CA2, CA6, CHRM1 MMP1 1032/4885MMP2 2303/4885MMP3 3421/4885
US-10287165-B2 Imidic acid compound having divalent anion and process for producing the same CA2, CA6, CHRM1 MMP1 1032/4885MMP2 2303/4885MMP3 3421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.